LU
Lunai Bioworks Inc.
RENB | US
Overview
Corporate Details
- ISIN(s):
- US29350E1047
- LEI:
- Country:
- United States of America
- Address:
- CENTURY CITY MEDICAL PLAZA, 90067 SUITE 906 LOS ANGELES
- Website:
- https://www.lunaibio.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Lunai Bioworks Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Lunai Bioworks Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Lunai Bioworks Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America
REFR
United States of America
REFR
Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.
Sweden
RESP
Sweden
RESP
Develops therapies that reprogram the innate immune system to reduce inflammation-related damage.
United States of America
REVB
United States of America
REVB
Clinical-stage biopharma developing novel therapies for CNS, respiratory, and metabolic diseases.
United States of America
RVPH
United States of America
RVPH
A clinical-stage oncology company developing targeted therapies for RAS-addicted cancers.
United States of America
RVMD
United States of America
RVMD
Uses 3D bioprinting and AI for autologous organ regeneration to treat chronic conditions.
South Korea
376900
South Korea
376900
Developing first-in-class, pre-clinical medicines for hard-to-treat cancers.
United Kingdom
ROQ
United Kingdom
ROQ
Clinical-stage drug discovery company developing novel small molecule therapies for oncology.
Poland
RVU
Poland
RVU
Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.
United States of America
SLRX
United States of America
SLRX
Develops electric calcination tech to decarbonize heavy industries like cement and capture CO2.
Sweden
SALT
Sweden
SALT